Zusammenfassung
Antiemetika und Antivertiginosa werden zur Behandlung von Erbrechen und Schwindel eingesetzt. Der weitaus größte Teil der Verordnungen entfällt auf Betahistin für Patienten mit Morbus Menière. Schwerpunkt der H1-Antihistaminika sind Prophylaxe und symptomatische Therapie von Übelkeit und Erbrechen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Baloh RW (2003): Clinical practice. Vestibular neuritis. N Engl J Med 348: 1027–1032.
Billio A, Morello E, Clarke MJ (2010): Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD00627–2.
Brandt T, Dichgans J, Diener HC (Hrsg) (1998): Therapie und Verlauf neurologischer Erkrankungen. 3. Aufl, Verlag Kohlhammer, Stuttgart Berlin Köln S. 127–156.
Hamann K-F, Arnold W (1999): Menière's disease. In: Büttner U (ed): Vestibular dysfunction and its therapy. Adv ORL 55: 137–168.
Ihler F, Bertlich M, Sharaf K, Strieth S, Strupp M, Canis M (2012): Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo. PLoS One 7: e3908–6
James A, Burton MJ (2009): Betahistine for Ménière's disease or syndrome. Cochrane Database of Systematic Reviews 2001, Issue 1. Publication status and date: Edited (no change to conclusions), published in Issue 1, 2009. Art. No.: CD001873. DOI: 10.1002/14651858. CD001873.
Kranke P, Morin AM, Roewer N, Eberhart LH (2002): Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand 46: 238–244.
Lacour M, van de Heyning PH, Novotny M, Tighilet B (2007): Betahistine in the treatment of Ménière's disease. Neuropsychiatr Dis Treat 3: 441–453.
Molino A, Guglielmo L, Azzolini ME, Biondani P, Capelli MC, Grandinetti A, Griso C, Martinelli G, Martini N, Zanotti R, et al. (1991): The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study. Oncology 48: 111–115.
Spinks AB, Wasiak J, Villanueva EV, Bernath V (2007): Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD00285–1.
Strupp M, Brandt T (2013): Peripheral vestibular disorders. Curr Opin Neurol 26: 81-89.
Westhofen M (2009): M. Menière. Evidenzen und Kontroversen. HNO 57: 446–454.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hamann, KF. (2014). Antiemetika und Antivertiginosa. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs- Report 2014. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43487-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-43487-1_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43486-4
Online ISBN: 978-3-662-43487-1
eBook Packages: Medicine (German Language)